Display options
Cite
Ebrahimi E, Almasi-Hashiani A, Ghaffari K, et al. Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors. EXCLI J. 2018;17:149-158doi: 10.17179/excli2017-819.
Ebrahimi, E., Almasi-Hashiani, A., Ghaffari, K., & Shirkoohi, R. (2018). Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors. EXCLI journal, 17149-158. https://doi.org/10.17179/excli2017-819
Ebrahimi, Elmira, et al. "Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors." EXCLI journal vol. 17 (2018): 149-158. doi: https://doi.org/10.17179/excli2017-819
Ebrahimi E, Almasi-Hashiani A, Ghaffari K, Shirkoohi R. Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors. EXCLI J. 2018 Jan 22;17:149-158. doi: 10.17179/excli2017-819. eCollection 2018. PMID: 29743853; PMCID: PMC5938539.
Copy Download .nbib Format: NLM
Share it on

EXCLI J. 2018 Jan 22;17:149-158. doi: 10.17179/excli2017-819. eCollection 2018.

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors.

EXCLI journal

Elmira Ebrahimi, Amir Almasi-Hashiani, Kimia Ghaffari, Reza Shirkoohi

Affiliations

  1. Cancer Biology Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  2. Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

PMID: 29743853 PMCID: PMC5938539 DOI: 10.17179/excli2017-819

Abstract

Increase in the copy number of

Keywords: Epidermal Growth Factor Receptor; breast cancer; gene amplification; genomic instability; mitochondrial DNA

References

  1. J Carcinog Mutagen. 2013;2013(Suppl 7):null - PubMed
  2. Nat Rev Endocrinol. 2014 May;10(5):303-10 - PubMed
  3. Biol Chem. 2016 Jul 1;397(7):607-15 - PubMed
  4. Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):179-87 - PubMed
  5. PLoS One. 2013 Jun 12;8(6):e65968 - PubMed
  6. Ann N Y Acad Sci. 2005 May;1042:109-22 - PubMed
  7. Clin Cancer Res. 2005 Apr 1;11(7):2486-91 - PubMed
  8. Nat Commun. 2012;3:1271 - PubMed
  9. Mol Reprod Dev. 2005 Aug;71(4):405-13 - PubMed
  10. JAMA. 2004 Apr 28;291(16):1972-7 - PubMed
  11. Clin Breast Cancer. 2004 Apr;5(1):63-9 - PubMed
  12. Endocr Relat Cancer. 2006 Mar;13(1):39-49 - PubMed
  13. Genome Res. 2015 May;25(5):633-44 - PubMed
  14. Cancer Sci. 2014 Jun;105(6):639-45 - PubMed
  15. EMBO J. 2005 Oct 5;24(19):3482-92 - PubMed
  16. Tumour Biol. 2016 May;37(5):6035-44 - PubMed
  17. Br J Cancer. 2006 Oct 23;95(8):1087-91 - PubMed
  18. Asian Pac J Cancer Prev. 2004 Jan-Mar;5(1):24-7 - PubMed
  19. Int J Cancer. 2005 Oct 10;116(6):920-4 - PubMed
  20. Mitochondrion. 2013 Nov;13(6):577-91 - PubMed
  21. Carcinogenesis. 2004 Jun;25(6):1005-10 - PubMed
  22. J Korean Med Sci. 2008 Jun;23(3):414-20 - PubMed
  23. Genes Chromosomes Cancer. 2006 Jul;45(7):629-38 - PubMed
  24. Oncogene. 2000 Dec 11;19(53):6102-14 - PubMed
  25. Life Sci. 2011 Jul 18;89(3-4):65-71 - PubMed
  26. Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):954-8 - PubMed
  27. Oncologist. 2009 Apr;14 (4):320-68 - PubMed
  28. Breast Cancer Res Treat. 2011 Feb;126(1):27-36 - PubMed
  29. Mitochondrion. 2010 Jan;10(1):62-8 - PubMed
  30. Placenta. 2015 Aug;36(8):803-8 - PubMed
  31. J Oncol. 2011;2011:496189 - PubMed
  32. Mol Cell. 2011 Oct 21;44(2):325-40 - PubMed
  33. J Cancer Res Clin Oncol. 2009 Aug;135(8):983-9 - PubMed
  34. Cancer Lett. 1996 Aug 2;105(2):167-73 - PubMed
  35. BMC Cancer. 2006 Apr 18;6:93 - PubMed
  36. Mitochondrion. 2013 Sep;13(5):481-92 - PubMed
  37. Cancer Cell Int. 2009 Feb 18;9:5 - PubMed
  38. IUBMB Life. 2007 Jul;59(7):450-7 - PubMed
  39. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30 - PubMed
  40. Iran Biomed J. 2016 Sep;20(4):241-5 - PubMed
  41. Cell Death Differ. 2013 Dec;20(12):1644-53 - PubMed
  42. Biol Reprod. 2007 Feb;76(2):327-35 - PubMed
  43. Clin Cancer Res. 2009 Nov 1;15(21):6484-9 - PubMed

Publication Types